Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Circadian regulation of lung repair and regeneration
Amruta Naik, Kaitlyn M. Forrest, Oindrila Paul, Yasmine Issah, Utham K. Valekunja, Soon Y. Tang, Akhilesh B. Reddy, Elizabeth J. Hennessy, Thomas G. Brooks, Fatima Chaudhry, Apoorva Babu, Michael Morley, Jarod A. Zepp, Gregory R. Grant, Garret A. FitzGerald, Amita Sehgal, G. Scott Worthen, David B. Frank, Edward E. Morrisey, Shaon Sengupta
Amruta Naik, Kaitlyn M. Forrest, Oindrila Paul, Yasmine Issah, Utham K. Valekunja, Soon Y. Tang, Akhilesh B. Reddy, Elizabeth J. Hennessy, Thomas G. Brooks, Fatima Chaudhry, Apoorva Babu, Michael Morley, Jarod A. Zepp, Gregory R. Grant, Garret A. FitzGerald, Amita Sehgal, G. Scott Worthen, David B. Frank, Edward E. Morrisey, Shaon Sengupta
View: Text | PDF | Corrigendum
Research Article Pulmonology Virology

Circadian regulation of lung repair and regeneration

  • Text
  • PDF
Abstract

Optimal lung repair and regeneration are essential for recovery from viral infections, including influenza A virus (IAV). We have previously demonstrated that acute inflammation and mortality induced by IAV is under circadian control. However, it is not known whether the influence of the circadian clock persists beyond the acute outcomes. Here, we utilize the UK Biobank to demonstrate an association between poor circadian rhythms and morbidity from lower respiratory tract infections, including the need for hospitalization and mortality after discharge; this persists even after adjusting for common confounding factors. Furthermore, we use a combination of lung organoid assays, single-cell RNA sequencing, and IAV infection in different models of clock disruption to investigate the role of the circadian clock in lung repair and regeneration. We show that lung organoids have a functional circadian clock and the disruption of this clock impairs regenerative capacity. Finally, we find that the circadian clock acts through distinct pathways in mediating lung regeneration — in tracheal cells via the Wnt/β-catenin pathway and through IL-1β in alveolar epithelial cells. We speculate that adding a circadian dimension to the critical process of lung repair and regeneration will lead to novel therapies and improve outcomes.

Authors

Amruta Naik, Kaitlyn M. Forrest, Oindrila Paul, Yasmine Issah, Utham K. Valekunja, Soon Y. Tang, Akhilesh B. Reddy, Elizabeth J. Hennessy, Thomas G. Brooks, Fatima Chaudhry, Apoorva Babu, Michael Morley, Jarod A. Zepp, Gregory R. Grant, Garret A. FitzGerald, Amita Sehgal, G. Scott Worthen, David B. Frank, Edward E. Morrisey, Shaon Sengupta

×

Figure 6

Activation of Wnt signaling in tracheal organoids rescues the regenerative defect in the absence of Bmal1.

Options: View larger image (or click on image) Download as PowerPoint
Activation of Wnt signaling in tracheal organoids rescues the regenerati...
(A) Gene expression of Wnt3a from Bmal1creERT2neg lungs harvested at different time intervals determined by qPCR (n = 3–4 mice per time point, q = 0.014). (B) Representative immunoblot of β-catenin expression from whole-lung extracts from Bmal1creERT2neg and Bmal1creERT2/+ mice. (C) Quantification of β-catenin expression normalized to β-actin from 2 independent experiments (n = 4–5, *P < 0.01). (D) ChIP assay of BMAL1 occupancy on the Wnt3a promoter. mPer2 primers were used as positive controls for the analysis. Data are expressed as percentage of input level normalized to IgG control (n = 4, pooled from 2 independent experiments). *P = 0.04, unpaired 2-tailed t test with Welch’s correction. Tracheal organoids were supplemented with Wnt3a in DMSO. (E) Bmal1+/+ WT littermates, Bmal1–/– DMSO, Bmal1–/– Wnt3a. (G) Bmal1creERT2neg littermates DMSO, Bmal1creERT2/+ DMSO, and Bmal1creERT2/+ Wnt3a CFE for (F) Bmal1–/– and (H) Bmal1creERT2/+. *P = 0.01,**P = 0.001, ****P = 0.0001. (I) AT2 organoids were supplemented with IL-1β (10 ng/mL) and DMSO (0.05% final concentration). (J) CFE: *P = 0.04, **P = 0.008, ***P = 0.0004. Scale bars: 2000 μm. Data pooled from 3–5 independent experiments with at least 3 technical replicates/experiment expressed as mean ± SEM. Kruskal-Wallis test with Dunn’s multiple-comparison test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts